The rapid preliminary FCM diagnosis in conjunction with clinical parameters (patient age) and serum PSA levels identified 13/14 (sensitivity 93%, specificity 95%, Κ = 0.88) patients with a tumor disease requiring intervention. Here, KLK3 is linked to neoplasm.